Results 151 to 160 of about 77,446 (306)

Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation

Nature Metabolism, 2021
Jui-Hsia Weng, P. Koch, Harding H. Luan, Ho-Chou Tu, K. Shimada, I. Ngan, Richard Ventura, Ruomu Jiang, T. Mitchison   +8 more
semanticscholar   +1 more source

THE MECHANISM OF COLCHICINE INHIBITION OF MITOSIS [PDF]

, 1965
Edwin W. Taylor
openalex   +1 more source

Concomitant use of metformin and proton pump inhibitors increases vitamin B12 deficiency risk in type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
The concomitant use of metformin and PPI was significantly associated with an increased risk of vitamin B12 deficiency in patients with type 2 diabetes. ABSTRACT Introduction Vitamin B12 deficiency is one of the adverse drug reactions of metformin and proton pump inhibitors (PPIs).
Choungwon Jung, Soyoung Park, Hyunah Kim
wiley   +1 more source

Erectile dysfunction in dermatology and venereology: From aetiopathogenic mechanisms to practical considerations for dermato‐venereologists

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Multiple inflammatory, infectious and autoimmune dermato‐venereological conditions are associated with erectile dysfunction (ED) due to underlying intricate vasculogenic, neurogenic, endocrine and psychogenic mechanisms. It is recommended that practitioners screen dermatology patients for ED and associated comorbidities, provide personalized lifestyle ...
Andrei Tanasov, George‐Sorin Tiplica
wiley   +1 more source

Morphological Variability of the Nuclear Substance and Genetic Changes induced by Colchicine in Escherichia coli

, 1949
J. Šterzl
openalex   +1 more source

Mutations and Reversions in Reproductivity of Aspergilli with Nitrite, Colchicine and d-Lysine

, 1940
Robert A. Steinberg, Charles Thom
openalex   +1 more source

CILIA REGENERATION IN TETRAHYMENA AND ITS INHIBITION BY COLCHICINE [PDF]

, 1969
Joel L. Rosenbaum, Kathryn E. Carlson
openalex   +1 more source

Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The only clinically approved drug that reduces doxorubicin cardiotoxicity is dexrazoxane, but its application is limited due to the risk of secondary malignancies.
Ying Peng, Zhonggen Li, Jianchao Zhang, Yunshu Dong, Chenglin Zhang, Yiming Dong, Yafei Zhai, Honglin Zheng, Mengduan Liu, Jing Zhao, Wenting Du, Yangyang Liu, Liping Sun, Xiaowei Li, Hailong Tao, Deyong Long, Xiaoyan Zhao, Xin Du, Changsheng Ma, Yaohe Wang, Jianzeng Dong   +20 more
doaj   +1 more source

Further Studies on the Effect of Colchicine upon the Mitosis of the Stamen Hair in Tradescantia

, 1949
Bungo Wada
openalex   +2 more sources

The Dissociation by Colchicine of Phagocytosis from Increased Oxygen Consumption in Human Leukocytes* [PDF]

, 1967
Stephen E. Malawista, Phyllis Bodel
openalex   +1 more source